Hem › Endometriecancer › North Carolina › Raleigh
Kliniska studier för Endometriecancer i Raleigh, NC
5 studier för Endometriecancer söker deltagare vid platser i och runt Raleigh (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekryterarFas 3
- Duke Women's Cancer Care Raleigh, Raleigh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Duke Women's Cancer Care Raleigh, Raleigh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekryterarFas 2
- Duke Women's Cancer Care Raleigh, Raleigh
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RekryterarFas 2
- Duke Womens Cancer Care Raleigh, Raleigh
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Investigative Site #131, Raleigh
Endometriecancer-studier i andra städer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andra studier i Raleigh
- Hjärtsvikt7 studier
- Kranskärlssjukdom6 studier
- Övervikt6 studier
- Typ 2-diabetes6 studier
- Makuladegeneration6 studier
- Ateroskleros5 studier
- Övervikt5 studier
- Hjärt-kärlsjukdom5 studier
- Stroke5 studier
- Njursvikt4 studier
- Diabetes4 studier
- Äggstockscancer4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.